MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO
https://t.co/RZdCpG0iWG
ESMO announces Funda Meric-Bernstam as the recipient of 2024 TAT Honorary Award for her outstanding contributions to #PrecisionOncology.
📅 She will deliver her award lecture on 26 February at the #ESMOTAT24 in Paris
📌https://t.co/tU4ihu42zE.
#ESMOTAT24: Early registration deadline 📢⏲️ 10 January 2024 at 23:59 (CET). Watch @LSeymourMD, Shivaani Kummar, Irene Braña, Timothy Yap, @lillian_siu, @ElenaGarralda & @AnastasiosStat2 give their takes on why you should attend. 👇
https://t.co/Z7y9otbFyQ
#ESMOTAT24: Last few hours to make sure you are part of this international multi-stakeholder forum in the early drug development arena. ⏰Abstract submission deadline today (28/11, 21:00 CET)
https://t.co/x14Z9dn28y
@lillian_siu @ElenaGarralda @AnastasiosStat2
#ESMOTAT24: Be part of this international multi-stakeholder forum in the early drug development arena! Merit travel grants are available. ⏰Abstract submission deadline: 28 November 2023.
https://t.co/Flg1468uaH
@lillian_siu @ElenaGarralda @AnastasiosStat2
#ESMOTAT24: Shape the future of cancer #drugdevelopment and take part in this unique forum gathering all relevant stakeholders in #oncology. ⏰Abstract submission deadline: 28 November 2023.
https://t.co/lsqGSsH3Rq
@lillian_siu @ElenaGarralda @AnastasiosStat2
#ESMOTAT24 taking place Feb 26-28, 2024, in Paris! Abstract submission now open till Nov 28, 2023: https://t.co/DyPdB0b9xO @myESMO
New meeting features with parallel industry sessions - not to be missed
@thanosplevris Το σύστημα υγείας στην Ελλάδα είναι κατεστραμμένο και έχετε τεράστια ευθύνη και εσείς και οι φίλοι σας διοικητές των νοσοκομείων (που γίνονται φυσικά διοικητές μόνο επειδή φίλοι σας)
📢🗓The #17ICML Scientific Program, based on more than 800 submitted abstracts, is almost ready!
Watch the video to have a sneak peek of the 17-ICML and stay tuned!